𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of mania patients suitable for treatment trials versus clinical treatment

✍ Scribed by Alessandra Talamo; Ross J. Baldessarini; Franca Centorrino


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
95 KB
Volume
23
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

It remains uncertain whether bipolar disorder (BPD) patients in randomized‐controlled trials (RCTs) are sufficiently representative of clinically encountered patients as to guide clinical‐therapeutic practice. We complied inclusion/exclusion criteria by frequency from reports of 21 RCTs for mania, and applied them in a pilot study of patients hospitalized for DSM‐IV BPD manic/mixed states to compare characteristics and clinical responses of patients who did versus did not meet exclusion criteria. From 27 initially identified inclusion/exclusion criteria ranked by citation frequency, we derived six inclusion, and 10 non‐redundant‐exclusion factors. Of 67 consecutive patients meeting inclusion criteria, 15 (22.4%) potential “research subjects” met all 10 exclusion criteria. The remaining 52 “clinical patients” differed markedly on exclusion criteria, including more psychiatric co‐morbidity, substance abuse, involuntary hospitalization, and suicide attempts or violence, but were otherwise similar. In both groups responses to clinically determined inpatient treatments were similar, including improvement in mania ratings. Based on applying reported inclusion/exclusion criteria for RCTs to a pilot sample of hospitalized‐manic patients, those likely to be included in modern RCTs were similar to patients who would be excluded, most notably in short‐term antimanic‐treatment responses. The findings encourage further comparisons of subjects included/excluded from RCTs to test potential clinical generalizability of research findings. The pilot study is limited in numbers and exposure times with which to test for the minor differences between “research subjects” and “clinical patients.” Copyright © 2008 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Treatment of acute mania—from clinical t
✍ Michel Bourin; Olivier Lambert; Bernard Guitton 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

No consensus has been reached with regard to the treatment of bouts of acute mania in various parts of the world. Controlled clinical trials have, at last, provided irrefutable evidence of the activity of lithium, which has long been used alone, as well as that of divalproate or its derivatives and,

SURVIVAL ANALYSES OF RANDOMIZED CLINICAL
✍ MATTHEW G. LAW; JOHN M. KALDOR 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

Patients who switch treatment groups in randomized clinical trials can cause problems in the interpretation of the results. Although the intention-to-treat method is recognized as being the most reliable analysis, it may result in an underestimate of the treatment effect if there have been patients

A comparison of various estimators of a
✍ B. Jones; D. Teather; J. Wang; J. A. Lewis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

When a clinical trial is conducted at more than one centre it is likely that the true treatment effect will not be identical at each centre. In other words there will be some degree of treatment-by-centre interaction. A number of alternative approaches for dealing with this have been suggested in th